A C Argent1, M Hatherill, C J L Newth, M Klein. 1. Division of Paediatric Critical Care and Children's Heart Disease, Red Cross War Memorial Children's Hospital and University of Cape Town, Rondebosch, 7700 Cape Town, South Africa. andrew.argent@uct.ac.za
Abstract
OBJECTIVES: To demonstrate that tests of pulmonary function applicable to sick infants and small children with acute severe viral croup would provide clear, objective evidence of responsiveness to therapy with nebulized epinephrine. STUDY DESIGN: Oesophageal pressure changes and airflows at the mouth were measured in 17 patients with acute severe croup, before and after nebulization with epinephrine. RESULTS: In 12 of the 17 patients there was a significant improvement in respiratory mechanics following epinephrine nebulization. Six of the 12 patients who responded to adrenaline also received 0.9% saline by nebulization, without improvement. No measures derived from combined flow and volume data showed any statistically significant change following epinephrine nebulization. Measures combining flow and pressure data, specifically inspiratory airway resistance, expiratory airway resistance, work of breathing, rate of work of breathing and volume for effort, showed changes of 26%, 33%, 16%, 16% and 46% respectively. The most statistically significant measures were pressure-rate product, pressure-time integral, oesophageal pressure alone and expiratory resistance. These changes persisted for at least 10 min after inhalation although there was some evidence of decline in pharmacologic effect at that time. CONCLUSIONS: Nebulized epinephrine results in a short-lived improvement in some but not all patients with croup. This reduction in respiratory effort occurs secondary to a decline in inspiratory and expiratory airway resistance. Oesophageal pressures measured via a feeding tube are satisfactory for quantification of the acute response and may be a useful continuous monitoring device. Flow measurements are unhelpful, and continuous administration of nebulized epinephrine should be investigated.
OBJECTIVES: To demonstrate that tests of pulmonary function applicable to sick infants and small children with acute severe viral croup would provide clear, objective evidence of responsiveness to therapy with nebulized epinephrine. STUDY DESIGN: Oesophageal pressure changes and airflows at the mouth were measured in 17 patients with acute severe croup, before and after nebulization with epinephrine. RESULTS: In 12 of the 17 patients there was a significant improvement in respiratory mechanics following epinephrine nebulization. Six of the 12 patients who responded to adrenaline also received 0.9% saline by nebulization, without improvement. No measures derived from combined flow and volume data showed any statistically significant change following epinephrine nebulization. Measures combining flow and pressure data, specifically inspiratory airway resistance, expiratory airway resistance, work of breathing, rate of work of breathing and volume for effort, showed changes of 26%, 33%, 16%, 16% and 46% respectively. The most statistically significant measures were pressure-rate product, pressure-time integral, oesophageal pressure alone and expiratory resistance. These changes persisted for at least 10 min after inhalation although there was some evidence of decline in pharmacologic effect at that time. CONCLUSIONS: Nebulized epinephrine results in a short-lived improvement in some but not all patients with croup. This reduction in respiratory effort occurs secondary to a decline in inspiratory and expiratory airway resistance. Oesophageal pressures measured via a feeding tube are satisfactory for quantification of the acute response and may be a useful continuous monitoring device. Flow measurements are unhelpful, and continuous administration of nebulized epinephrine should be investigated.
Authors: J E Weber; C R Chudnofsky; J G Younger; G L Larkin; M Boczar; M D Wilkerson; G Y Zuriekat; B Nolan; D M Eicke Journal: Pediatrics Date: 2001-06 Impact factor: 7.124
Authors: Paulo Sérgio Lucas da Silva; Marcelo Cunio Machado Fonseca; Simone Brasil Oliveira Iglesias; Emílio Lopes Junior; Vânia Euzébio de Aguiar; Werther Brunow de Carvalho Journal: Intensive Care Med Date: 2011-11-26 Impact factor: 17.440
Authors: Robinder G Khemani; Justin Hotz; Rica Morzov; Rutger Flink; Asavari Kamerkar; Patrick A Ross; Christopher J L Newth Journal: Am J Respir Crit Care Med Date: 2016-01-15 Impact factor: 21.405
Authors: Robinder G Khemani; James B Schneider; Rica Morzov; Barry Markovitz; Christopher J L Newth Journal: J Crit Care Date: 2013-01-18 Impact factor: 3.425
Authors: Robinder G Khemani; Justin Hotz; Rica Morzov; Rutger C Flink; Asvari Kamerkar; Marie LaFortune; Gerrard F Rafferty; Patrick A Ross; Christopher J L Newth Journal: Intensive Care Med Date: 2016-06-18 Impact factor: 17.440
Authors: Robinder G Khemani; Rutger Flink; Justin Hotz; Patrick A Ross; Anoopindar Ghuman; Christopher J L Newth Journal: Pediatr Res Date: 2014-10-03 Impact factor: 3.756
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2009-02-10 Impact factor: 17.440
Authors: Justin C Hotz; Dinnel Bornstein; Kristen Kohler; Erin Smith; Anil Suresh; Margaret Klein; Anoopindar Bhalla; Christopher J Newth; Robinder G Khemani Journal: Pediatr Crit Care Med Date: 2020-11 Impact factor: 3.971